Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events

Liraglutide is a GLP-1 analog (glucagon like peptide-1) used primarily in the treatment of diabetes mellitus type 2 (DM2) and obesity. The literature starts to suggest that liraglutide may reduce the effects of ischemic stroke by activating anti-apoptotic pathways, as well as limiting the harmful ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiciński, Michał, Socha, Maciej, Malinowski, Bartosz, Wódkiewicz, Eryk, Walczak, Maciej, Górski, Karol, Słupski, Maciej, Pawlak-Osińska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429395/
https://www.ncbi.nlm.nih.gov/pubmed/30823403
http://dx.doi.org/10.3390/ijms20051050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429395/
https://www.ncbi.nlm.nih.gov/pubmed/30823403
http://dx.doi.org/10.3390/ijms20051050

Ejemplares similares